Skip to main content

Report 2021 – DNA Sequencing Market Size, Share, Growth, Revenue, Trends, Competitive Landscape, Forecast Report

Written by Customer Service on . Posted in Mergers And Acquisitions.

Pune, India, Feb. 11, 2021 (GLOBE NEWSWIRE) — According to the report, DNA Sequencing market size is projected to reach remarkable value by 2026. The rising advancements in DNA sequencing technologies is expected to enable growth of the global DNA sequencing market. The rising prevalence of various cancers and genetic diseases is expected to contribute to growth of the market.The collaboration of Nebula Genomics with Merck KGaA is predicted to aid growth of the DNA sequencing market. For instance, Nebula Genomics announced its collaboration Merck KGaA with the goal to enhance drug discovery for lung cancer patients and offering a free high-coverage germ line and tumor whole-genome sequencing.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/dna-sequencing-market-101527
Increasing Partnerships And Collaborations Will Encourage Growth
           
The launch of Morphoseq Long Read DNA Sequencing Technology is predicted to contribute to the DNA sequencing market growth. For instance, Longas Technologies launched Morphoseq Long Read DNA Sequencing Technology which is designed to improve the NGS platforms by increasing effective read lengths, providing benefits of high accuracy and cost efficiency sequencing.Furthermore, increasing applications of DNA sequencing in imaging, nanotechnology, bioinformatics, and development of effective gene therapy, for the treatment of various types of diseases are likely to drive the DNA sequencing market growth during the forecast period. In addition, growing applications of DNA sequencing in pharmacogenomics will fuel demand for the development of personalized medicines. This factor will boost the market growth during the forecast period.However, the lack of skilled professionals and low awareness about the emerging technologies in DNA sequencing in low-middle income countries is likely to hinder the growth of the market during the forecast period.The rising adoption of new technology in DNA sequencing and surge inpatient population will further stimulate growth in the region. In the Middle East & Africa, growing unmet needs for the cost-effective diagnosis of various diseases is likely to accelerate the growth of the market in the region.
Click here to get the short-term and long-term impacts of COVID-19 on this Market.Please visit: https://www.fortunebusinessinsights.com/industry-reports/dna-sequencing-market-101527
Presence Of Key Players Will Enable Growth North AmericaNorth America is expected to dominate the market during the forecast period owing to the presence of key players in the region. The rising prevalence of various genetic disorders and growing investments by key players for the development of technological advanced DNA sequencing technology will further boost growth in North America.  In Europe, rising awareness about the growing application of DNA sequencing in developing effective gene therapy is likely to drive the market during the forecast period. In the Asia Pacific and Latin America, the market is expected to grow at a significant rate owing to the growing prevalence of various chronic disorders & cancers.
Quick Buy –  DNA Sequencing Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/101527
Several companies present in the global market for DNA Sequencing are striving to compete with their rivals by either engaging in mergers & acquisitions, or by conducting novel clinical research studies.Abbott, DanaherF. Hoffmann-La Roche Ltd Illumina, Inc.LI-COR, Inc.Pacific Biosciences of California, Inc. SiemensThermo Fisher Scientific Inc. PerkinElmer Inc.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/queries/dna-sequencing-market-101527
Global DNA Sequencing Market Segmentation:By Type:         InstrumentsReagents & ConsumablesWorkflow ProductsServicesBy Technology:         Next Generation DNA SequencingSanger SequencingBy Application:         Research & Clinical TrialsDisease DiagnosisForensicsOthersBy End-User:Biotechnology & Pharmaceutical IndustriesDiagnostic CentersHospitals & ClinicsAcademic & Research InstitutesOthersBy GeographyNorth America (U.S. and Canada)Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)Latin America (Brazil, Mexico, and Rest of Latin America)Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/dna-sequencing-market-101527
Have a Look at Related Reports:Neonatal Intensive Care Market Size, Share & Industry Analysis, By Product (Neonatal Incubators, Neonatal Phototherapy Equipment, Neonatal Ventilators, Neonatal Monitors, and Others), By End User (Hospitals, and Specialty Clinics), and Regional Forecast, 2020-2027Lymphoma Treatment Market Size, Share & Industry Analysis, By Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, and Others), By Disease Type (Non-Hodgkin Lymphoma, and Hodgkin Lymphoma), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Regional Forecast, 2019-2026Diabetic Neuropathy Market Size, Share & Industry Analysis, By Disease Type (Peripheral, Autonomic, Proximal, and Focal), By Drug Class (Anti-Depressants, Anti-Seizures, Opioid, Non-Steroidal Anti-Inflammatory, and others), By Distribution Channel (Hospital Pharmacies, Retails Pharmacies & Stores, and Online Pharmacies), and Regional Forecast, 2019-2026Teleradiology Market Size, Share & Industry Analysis, By Imaging Technique (X-Ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound, Nuclear Medicine, and Others), By Component (Services & Software, and Product), By End User (Hospitals & Clinics, Diagnostic Centers and Others), and Regional Forecast, 2019-2026Transcatheter Heart Valve Replacement (THVR) Market Size, Share & Industry Analysis, By Product Type (Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Replacement (TMVR), and Transcatheter Pulmonary Valve Replacement (TPVR)), By End User (Hospitals, and Specialty Clinics& Others), and Regional Forecast, 2019-2026
About Us:Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.